Search

Search Constraints

You searched for: Author/Creator Chui, Celine Sze Ling

Search Results

2. Adverse events of special interest following the use of BNT162b2 in adolescents: a population-based retrospective cohort study. Issue 1 (31st December 2022)

3. Association between the risk of seizure and COVID‐19 vaccinations: A self‐controlled case‐series study. Issue 12 (29th October 2022)

4. Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. Issue 1 (January 2022)

5. Comparing self-reported reactogenicity between adolescents and adults following the use of BNT162b2 (Pfizer-BioNTech) messenger RNA COVID-19 vaccine: a prospective cohort study. (March 2022)

6. COVID‐19 vaccines and risks of hematological abnormalities: Nested case–control and self‐controlled case series study. Issue 4 (9th February 2022)

7. Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case–control study. Issue 1 (31st December 2022)

8. Lack of inflammatory bowel disease flare-up following two-dose BNT162b2 vaccine: a population-based cohort study. Issue 12 (8th February 2022)

9. Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination With BNT162b2 Increased Risk of Bell's Palsy: A Nested Case-Control and Self-Controlled Case Series Study. (7th June 2022)

10. Post‐Covid‐19‐vaccination adverse events and healthcare utilization among individuals with or without previous SARS‐CoV‐2 infection. (1st February 2022)